We are live on ! Find out more
LMAT icon

LeMaitre Vascular

220 hedge funds and large institutions have $1.06B invested in LeMaitre Vascular in 2023 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 94 increasing their positions, 71 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,945% more call options, than puts

Call options by funds: $670K | Put options by funds: $22K

43% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 21

32% more repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 71

4% more funds holding

Funds holding: 212220 (+8)

1.71% more ownership

Funds ownership: 85.81%87.51% (+1.7%)

16% less capital invested

Capital invested by funds: $1.27B → $1.06B (-$206M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
220
Holders Change
+8
Holders Change %
+3.77%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
30
Increased
94
Reduced
71
Closed
21
Calls
$670K
Puts
$22K
Net Calls
+$648K
Net Calls Change
+$668K
Name Holding Trade Value Shares
Change
Change in
Stake
CRM
26
Cramer Rosenthal McGlynn
Connecticut
$8.57M +$145K +2,453 +2%
ProShare Advisors
27
ProShare Advisors
Maryland
$7.65M +$733K +12,365 +10%
DCM
28
Driehaus Capital Management
Illinois
$6.59M +$1.07M +17,982 +17%
BG
29
Bahl & Gaynor
Ohio
$6.56M -$345K -5,815 -5%
CIC
30
Crawford Investment Counsel
Georgia
$6.51M +$674K +11,379 +11%
N
31
Nuveen
North Carolina
$6.46M -$21.3K -360 -0.3%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$6.01M +$272K +4,593 +4%
Principal Financial Group
33
Principal Financial Group
Iowa
$5.91M -$253K -4,264 -4%
Marshall Wace
34
Marshall Wace
United Kingdom
$5.28M +$2M +33,702 +53%
Two Sigma Investments
35
Two Sigma Investments
New York
$5.21M +$644K +10,874 +13%
Renaissance Technologies
36
Renaissance Technologies
New York
$5M +$954K +16,100 +21%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$4.89M -$534K -9,013 -9%
Invesco
38
Invesco
Georgia
$4.62M -$4.3M -72,635 -46%
Goldman Sachs
39
Goldman Sachs
New York
$4.51M -$2.25M -37,987 -31%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$4.46M +$83K +1,400 +2%
CWM
41
Congress Wealth Management
Massachusetts
$4.28M +$226K +3,812 +5%
Victory Capital Management
42
Victory Capital Management
Texas
$4.19M +$33K +557 +0.7%
CSS
43
Cubist Systematic Strategies
Connecticut
$3.34M +$3.64M +61,396 New
BCC
44
Bridge City Capital
Oregon
$3.21M +$104K +1,750 +3%
OAM
45
Oberweis Asset Management
Illinois
$3.11M +$1.51M +25,400 +80%
Legal & General Group
46
Legal & General Group
United Kingdom
$2.99M -$32.4K -546 -1%
AG
47
Algert Global
California
$2.78M +$2.69M +45,400 +818%
Balyasny Asset Management
48
Balyasny Asset Management
Illinois
$2.59M +$2.82M +47,509 New
Stifel Financial
49
Stifel Financial
Missouri
$2.48M +$196K +3,305 +8%
Swiss National Bank
50
Swiss National Bank
Switzerland
$2.39M +$29.6K +500 +1%

LMAT Hedge Fund Activity: Q3 2023 in Review

220 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2023, worth a combined $1.06B — down 16% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new LMAT positions and 21 closed out — a net gain of 9 holders — while 94 added to existing stakes and 71 trimmed.

The largest buyer was Congress Asset Management, adding an estimated $8.02M. The largest seller was Millennium Management, cutting an estimated $4.36M.

  • 220 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2023, up from 212 in Q2 2023.
  • Funds reported $1.06B of LeMaitre Vascular stock for Q3 2023, down 16% quarter-over-quarter.
  • 30 funds opened new LeMaitre Vascular positions in Q3 2023 and 21 closed out, a net change of +9 holders.
  • The largest LeMaitre Vascular buyer in Q3 2023 was Congress Asset Management, an estimated $8.02M added.
  • The largest LeMaitre Vascular seller in Q3 2023 was Millennium Management, an estimated $4.36M sold.

Based on aggregated 13F filings for Q3 2023.